Denali Therapeutics (DNLI) FCF/share US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
FCF/share, rub | -1.77 | 3.79 | -1.81 | -2.09 | -2.70 | -2.22 | ||
Changes by years, y/y, % | -451% | -314% | -148% | +16% | +29% |
Denali Therapeutics. FCF/share, rub
Denali Therapeutics. FCF/share, changes, %
Denali Therapeutics (DNLI) FCF/share US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
FCF/share, rub | -0.65 | -0.73 | -0.77 | -0.57 | -0.37 | -2.22 | ||
Changes by years, y/y, % | +27% | +25% | +72% | -35% | -43% | |||
Changes by quarters, q/q, % | -25% | +12% | +6% | -27% | -35% |